--(BUSINESS WIRE)--AMPLEXOR Life Sciences:
MEDIA ADVISORY: |
From addressing the evolving regulations to exploring the potential of disruptive technologies that help manage your packaging and labeling requirements, AMPLEXOR’s Kathleen O’Brien and David Gwyn will present a case study related to insights about deviations in local labeling and shed light on the path forward at the forthcoming Pharma Packaging and Labeling, East Coast 2019 conference. |
|
|
||
Now in its 11th year, Pharma Packaging and Labeling – East Coast delivers key, actionable insights into the very latest regulatory requirements, technological innovations, strategic developments, and how to implement them into the packaging and labeling chain with both maximum efficiency and minimal cost. |
||
An interactive and hands-on agenda includes: panel discussions, roundtables, speed networking, think tanks, and mini-workshops and will create an environment where commercial packaging and labeling teams from across all sizes of manufacturers can work together to manage creative, technical, and regulatory demands while ensuring patients are safeguarded at all stages. | ||
What: |
Join AMPLEXOR’s Kathleen O’Brien, Director of Business Development, and David Gwyn, Global Solution Architect, who will demonstrate how to manage the complexities of packaging and labeling compliance using the AMPLEXOR Life Sciences Suite. |
|
Thursday, 21 February 2019 | ||
9:30 a.m. | ||
Presentation titled, “Ensuring Compliance for Pharma Companies through Local Label Deviations: Stay Out of Hot Water with the Health Authorities” | ||
When: |
20 – 21 February 2019 | |
Booth #17 | ||
Where: |
Hilton Philadelphia City Avenue | |
4200 City Avenue | ||
Philadelphia, Pennsylvania |
Throughout the conference, AMPLEXOR’s Life Sciences and Language Services experts will be on-hand to discuss your organization’s packaging and labeling challenges, and how they can help you meet deadlines, adhere to regulations, and ensure compliance.
To register for the event, please visit here.
To learn more about the AMPLEXOR Life Sciences, please visit here.
About AMPLEXOR Life Sciences
AMPLEXOR Life Sciences helps pharmaceutical, medical device and biotechnology organizations launch products and break into new markets quickly. Our solutions and services expedite the creation and delivery of consistent, compliant and high-quality global content – both physical and digital – across all target countries. Services include technology consultancy, implementation and management services, as well as technical writing, medical translation and linguistic validation services.
AMPLEXOR employs 1,800 people in 23 countries across four continents and boasts a rich 25+ year history of serving pharmaceutical, medical device manufacturers and biotechnology companies. For more information, go to www.amplexor.com.